165 related articles for article (PubMed ID: 12504622)
21. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
[TBL] [Abstract][Full Text] [Related]
23. [Immunohistochemical study of the predictive value of oncoproteins p53, HER-2 and c-myc during radiotherapy for squamous cell carcinoma of the cervix].
Gasparian NA; Pozharisskiĭ KM; Zharinov GM; Vinokurov VL; Kuznetsova ME; Neklasova NIu
Vopr Onkol; 2007; 53(4):439-44. PubMed ID: 17969407
[TBL] [Abstract][Full Text] [Related]
24. Radiation therapy induced changes in apoptosis and its major regulatory proteins, Bcl-2, Bcl-XL, and Bax, in locally advanced invasive squamous cell carcinoma of the cervix.
Adhya AK; Srinivasan R; Patel FD
Int J Gynecol Pathol; 2006 Jul; 25(3):281-7. PubMed ID: 16810067
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of anti-apoptotic protein Bcl-2 in keratinizing versus non-keratinizing squamous cell carcinoma of the anus.
Allal AS; Bründler MA; Gervaz P
Int J Colorectal Dis; 2005 Mar; 20(2):161-4. PubMed ID: 15688099
[TBL] [Abstract][Full Text] [Related]
26. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities.
Sarbia M; Stahl M; Fink U; Willers R; Seeber S; Gabbert HE
Clin Cancer Res; 1998 Dec; 4(12):2991-7. PubMed ID: 9865911
[TBL] [Abstract][Full Text] [Related]
27. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease.
Shiohara S; Shiozawa T; Miyamoto T; Feng YZ; Kashima H; Kurai M; Suzuki A; Konishi I
Virchows Arch; 2005 Jun; 446(6):626-33. PubMed ID: 15891905
[TBL] [Abstract][Full Text] [Related]
28. Mutant p53 in patients with invasive cervical cancer stages IB to IIB.
Kainz C; Kohlberger P; Gitsch G; Sliutz G; Breitenecker G; Reinthaller A
Gynecol Oncol; 1995 May; 57(2):212-4. PubMed ID: 7729736
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.
Baekelandt M; Kristensen GB; Nesland JM; Tropé CG; Holm R
J Clin Oncol; 1999 Jul; 17(7):2061. PubMed ID: 10561259
[TBL] [Abstract][Full Text] [Related]
31. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic significance of expression of p53, bcl-2 and bax in squamous epithelial carcinoma of the larynx--a multivariate analysis].
Jäckel MC; Sellmann L; Youssef S; Dorudian MA; Füzesi L
HNO; 2001 Mar; 49(3):204-11. PubMed ID: 11320623
[TBL] [Abstract][Full Text] [Related]
33. P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer.
Sagarra RA; Andrade LA; Martinez EZ; Pinto GA; Syrjänen KJ; Derchain SF
Int J Gynecol Cancer; 2002; 12(6):720-7. PubMed ID: 12445249
[TBL] [Abstract][Full Text] [Related]
34. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract][Full Text] [Related]
35. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
[TBL] [Abstract][Full Text] [Related]
36. Detection of apoptosis and expression of apoptosis-associated proteins as early predictors of prognosis after irradiation therapy in stage IIIb uterine cervical cancer.
Yuki H; Fujimura M; Yamakawa Y; Hidaka T; Saito S
Jpn J Cancer Res; 2000 Jan; 91(1):127-34. PubMed ID: 10744054
[TBL] [Abstract][Full Text] [Related]
37. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.
Nakopoulou L; Vourlakou C; Zervas A; Tzonou A; Gakiopoulou H; Dimopoulos MA
Hum Pathol; 1998 Feb; 29(2):146-54. PubMed ID: 9490274
[TBL] [Abstract][Full Text] [Related]
38. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy.
Giatromanolaki A; Koukourakis M; Zaramboukas T; Skordalaki A; Arapantoni P; Georgoulias V; Fountzilas G
Anticancer Res; 1998; 18(6B):4685-92. PubMed ID: 9891541
[TBL] [Abstract][Full Text] [Related]
39. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
[TBL] [Abstract][Full Text] [Related]
40. Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancer.
Harima Y; Harima K; Shikata N; Oka A; Ohnishi T; Tanaka Y
J Cancer Res Clin Oncol; 1998; 124(9):503-10. PubMed ID: 9808425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]